PA8499101A1 - Composicion de ovulos intravaginales de clindamicina - Google Patents
Composicion de ovulos intravaginales de clindamicinaInfo
- Publication number
- PA8499101A1 PA8499101A1 PA20008499101A PA8499101A PA8499101A1 PA 8499101 A1 PA8499101 A1 PA 8499101A1 PA 20008499101 A PA20008499101 A PA 20008499101A PA 8499101 A PA8499101 A PA 8499101A PA 8499101 A1 PA8499101 A1 PA 8499101A1
- Authority
- PA
- Panama
- Prior art keywords
- clindamycin
- solid fat
- composition
- ovules
- intravaginal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
UNA COMPOSICION SUMAMENTE ESTABLE AL ALMACENAMIENTO PARA LA ADMINISTRACION VAGINAL DE CLINDAMICINA CONSTITUIDA DE UN SUPOSITORIO VAGINAL QUE CONTIENE UNA CANTIDAD ANTIMICROBIANA EFICAZ DE CLINDAMICINA DISPERSADA EN UNA BASE DE SUPOSITORIO DE GRASA SOLIDA, PREFERIBLEMENTE DEL TIPO GRASA SOLIDA NF. LAS BASES DE GRASA SOLIDA SON UNA MEZCLA DE GLICERIDOS DE ACIDOS GRASOS SUPERIORES SATURADOS. LAS BASES DE SUPOSITORIO DE GRASA SOLIDA NF PROVEEN UN PRODUCTO DE CLINDAMICINA QUE CONTIENE MAYOR ESTABILIDAD QUE LA FORMULACION DE CVC Y AL MISMO TIEMPO PROVEE UNA EFICACIA EQUIVALENTE CONTRA LA VB.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14756199P | 1999-08-06 | 1999-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8499101A1 true PA8499101A1 (es) | 2001-12-14 |
Family
ID=22522061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20008499101A PA8499101A1 (es) | 1999-08-06 | 2000-08-04 | Composicion de ovulos intravaginales de clindamicina |
Country Status (24)
Country | Link |
---|---|
US (2) | US6495157B1 (es) |
EP (1) | EP1200065B1 (es) |
JP (1) | JP2003519095A (es) |
KR (1) | KR100670085B1 (es) |
CN (1) | CN1160056C (es) |
AR (1) | AR025045A1 (es) |
AT (1) | ATE250408T1 (es) |
AU (1) | AU768907B2 (es) |
CA (1) | CA2378572A1 (es) |
DE (1) | DE60005524T2 (es) |
DK (1) | DK1200065T3 (es) |
ES (1) | ES2207532T3 (es) |
HK (1) | HK1047538A1 (es) |
HN (1) | HN2000000166A (es) |
MA (1) | MA26749A1 (es) |
MX (1) | MXPA02001320A (es) |
NZ (1) | NZ517039A (es) |
PA (1) | PA8499101A1 (es) |
PE (1) | PE20010484A1 (es) |
PT (1) | PT1200065E (es) |
SI (1) | SI1200065T1 (es) |
SV (1) | SV2001000138A (es) |
TW (1) | TWI232111B (es) |
WO (1) | WO2001010407A1 (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI232111B (en) * | 1999-08-06 | 2005-05-11 | Upjohn Co | Intravaginal clindamycin ovule composition |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
AU2002238063A1 (en) * | 2002-02-05 | 2004-02-25 | Pharmacia And Upjohn Company | Composition and method for rectal delivery of a lincosamide antibacterial drug |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
CA2533178C (en) | 2003-07-21 | 2014-03-11 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
AU2004258953B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005009364A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005016311A1 (en) | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
JP2007502294A (ja) | 2003-08-12 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
AU2004270170B2 (en) | 2003-08-29 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
AU2004273830B2 (en) | 2003-09-15 | 2011-03-24 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
EP1667619A4 (en) * | 2003-09-19 | 2007-10-10 | Drugtech Corp | PHARMACEUTICAL FEEDING SYSTEM |
US20060140990A1 (en) * | 2003-09-19 | 2006-06-29 | Drugtech Corporation | Composition for topical treatment of mixed vaginal infections |
US20050214364A1 (en) * | 2004-03-23 | 2005-09-29 | Hutman Herbert W | Products and methods for treating vaginal infections |
US20070065504A1 (en) * | 2004-03-23 | 2007-03-22 | Lin Shun Y | Products and methods for treating vaginal infections |
JP2008505124A (ja) | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
US20060078616A1 (en) * | 2004-08-30 | 2006-04-13 | Georgewill Dawaye A | Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol |
WO2006121979A2 (en) * | 2005-05-09 | 2006-11-16 | Drugtech Corporation | Modified-release pharmaceutical compositions |
CN100446774C (zh) * | 2005-05-31 | 2008-12-31 | 黑龙江龙桂制药有限公司 | 盐酸克林霉素阴道泡腾片及其制备方法 |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
EA200870153A1 (ru) * | 2006-01-05 | 2008-12-30 | Драгтек Корпорейшн | Композиция и способ ее использования |
CN101365425A (zh) * | 2006-01-05 | 2009-02-11 | 药物技术公司 | 用于生物粘附到外阴阴道表面的递药系统 |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
DE102009055644A1 (de) * | 2009-11-25 | 2011-06-01 | Nicole Nedela | Dildo-Set |
CN103735491B (zh) * | 2013-12-31 | 2016-01-13 | 哈尔滨欧替药业有限公司 | 克林霉素磷酸酯阴道膨胀栓及其制备方法和检测方法 |
US10813963B2 (en) | 2018-09-04 | 2020-10-27 | Babak Ghalili | Veterinary cannabinoid and menthol compositions and methods |
US10751299B2 (en) * | 2018-09-04 | 2020-08-25 | Babak Ghalili | Cannabinoid and menthol compositions and methods |
WO2021177938A1 (en) * | 2020-03-02 | 2021-09-10 | Babak Ghalili | Veterinary cannabinoid and menthol compositions and methods |
MX2020011523A (es) * | 2020-10-29 | 2022-05-02 | Exeltis Pharma Mexico S A De C V | Composicion farmaceutica adecuada para administracion vaginal en forma de ovulos y uso de la misma. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2812683B2 (ja) * | 1988-07-26 | 1998-10-22 | 富士製薬工業株式会社 | 持続性を有するモルヒネ直腸投与製剤 |
JPH05213752A (ja) * | 1992-02-06 | 1993-08-24 | Fujisawa Asutora Kk | 坐 剤 |
GB9610359D0 (en) * | 1996-05-17 | 1996-07-24 | Edko Trading Representation | Pharmaceutical compositions |
DE19737348C2 (de) * | 1997-08-27 | 2002-07-25 | Dan-Gabriel Vulpescu | Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung |
TWI232111B (en) * | 1999-08-06 | 2005-05-11 | Upjohn Co | Intravaginal clindamycin ovule composition |
-
2000
- 2000-07-17 TW TW089114267A patent/TWI232111B/zh not_active IP Right Cessation
- 2000-07-20 SI SI200030275T patent/SI1200065T1/xx unknown
- 2000-07-20 EP EP00948739A patent/EP1200065B1/en not_active Expired - Lifetime
- 2000-07-20 DK DK00948739T patent/DK1200065T3/da active
- 2000-07-20 US US09/619,930 patent/US6495157B1/en not_active Expired - Lifetime
- 2000-07-20 AU AU62198/00A patent/AU768907B2/en not_active Expired
- 2000-07-20 JP JP2001514928A patent/JP2003519095A/ja active Pending
- 2000-07-20 ES ES00948739T patent/ES2207532T3/es not_active Expired - Lifetime
- 2000-07-20 NZ NZ517039A patent/NZ517039A/xx not_active IP Right Cessation
- 2000-07-20 MX MXPA02001320A patent/MXPA02001320A/es active IP Right Grant
- 2000-07-20 PT PT00948739T patent/PT1200065E/pt unknown
- 2000-07-20 CN CNB008102031A patent/CN1160056C/zh not_active Expired - Lifetime
- 2000-07-20 DE DE60005524T patent/DE60005524T2/de not_active Expired - Lifetime
- 2000-07-20 WO PCT/US2000/019533 patent/WO2001010407A1/en active IP Right Grant
- 2000-07-20 KR KR1020027001576A patent/KR100670085B1/ko active IP Right Grant
- 2000-07-20 AT AT00948739T patent/ATE250408T1/de active
- 2000-07-20 CA CA002378572A patent/CA2378572A1/en not_active Abandoned
- 2000-08-02 HN HN2000000166A patent/HN2000000166A/es unknown
- 2000-08-04 MA MA26034A patent/MA26749A1/fr unknown
- 2000-08-04 PE PE2000000779A patent/PE20010484A1/es not_active IP Right Cessation
- 2000-08-04 PA PA20008499101A patent/PA8499101A1/es unknown
- 2000-08-04 AR ARP000104042A patent/AR025045A1/es not_active Application Discontinuation
- 2000-08-07 SV SV2000000138A patent/SV2001000138A/es active IP Right Grant
-
2002
- 2002-02-05 US US10/072,492 patent/US20020197320A1/en not_active Abandoned
- 2002-11-29 HK HK02108642A patent/HK1047538A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2378572A1 (en) | 2001-02-15 |
SV2001000138A (es) | 2001-10-24 |
EP1200065A1 (en) | 2002-05-02 |
AR025045A1 (es) | 2002-11-06 |
HN2000000166A (es) | 2001-04-20 |
AU768907B2 (en) | 2004-01-08 |
PE20010484A1 (es) | 2001-04-20 |
DK1200065T3 (da) | 2004-02-02 |
TWI232111B (en) | 2005-05-11 |
JP2003519095A (ja) | 2003-06-17 |
US20020197320A1 (en) | 2002-12-26 |
SI1200065T1 (en) | 2004-04-30 |
MA26749A1 (fr) | 2004-12-20 |
EP1200065B1 (en) | 2003-09-24 |
HK1047538A1 (en) | 2003-02-28 |
WO2001010407A1 (en) | 2001-02-15 |
ES2207532T3 (es) | 2004-06-01 |
MXPA02001320A (es) | 2004-09-10 |
KR100670085B1 (ko) | 2007-01-17 |
DE60005524T2 (de) | 2004-08-05 |
PT1200065E (pt) | 2004-02-27 |
AU6219800A (en) | 2001-03-05 |
ATE250408T1 (de) | 2003-10-15 |
KR20020038713A (ko) | 2002-05-23 |
US6495157B1 (en) | 2002-12-17 |
CN1160056C (zh) | 2004-08-04 |
DE60005524D1 (de) | 2003-10-30 |
NZ517039A (en) | 2003-01-31 |
CN1360495A (zh) | 2002-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8499101A1 (es) | Composicion de ovulos intravaginales de clindamicina | |
PA8559501A1 (es) | Formulaciones farmaceuticas de 5,7,14-triazatetraciclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaeno | |
AR029766A1 (es) | Compuesto inhibidor de quinasa y uso del mismo para preparar una composicion farmaceutica | |
ES2117015T3 (es) | Composiciones que contienen sumatriptan. | |
CY1108914T1 (el) | Μητρα για παρατεταμενη, αμεταβλητη και ανεξαρτητη απελευθερωση δραστικων ενωσεων | |
UY27304A1 (es) | Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación | |
ES2177422B1 (es) | Composiciones acaricidas. | |
PT1093819E (pt) | Compostos e composicoes para fornecimento de agentes activos | |
SV1995000002A (es) | Uso y obtencion de derivados tetraciclicos ref. 1233cv/vs | |
PE20010286A1 (es) | Derivados de indoloxoacetil piperazina como agentes antivirales | |
CO5180575A1 (es) | Composiciones antibacterianas orales de lupulona hidrogenda estable | |
ECSP055528A (es) | Composicion farmaceutica que tiene una distribución y potencia uniforme de farmaco | |
HN2004000232A (es) | " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden." | |
IL208697A0 (en) | Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol | |
AR024998A1 (es) | Nuevos retinoides para el tratamiento del enfisema | |
UY28356A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos | |
UY28524A1 (es) | Derivados de triazol sustituidos como antagonistas de oxitocina | |
AR029092A1 (es) | Composiciones para el tratamiento del cabello | |
UY28622A1 (es) | Agentes antibacterianos de quinolona | |
AR031358A1 (es) | Combinacion de inhibidores de calpaina y secuestrantes de especies de oxigeno reactivo | |
AR025351A1 (es) | Agonistas retinoides selectivos par | |
UY28535A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. | |
IT1250672B (it) | Formulazioni orali di ubidecarenone in soluzione acquosa | |
ES2150404T3 (es) | Composiciones farmaceuticas de tizoxanida y nitozoxanida. | |
ECSP003596A (es) | Composiciones de ovulos intravaginales de clindamicina |